| pubmed-article:6436966 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6436966 | lifeskim:mentions | umls-concept:C1527116 | lld:lifeskim |
| pubmed-article:6436966 | lifeskim:mentions | umls-concept:C0027912 | lld:lifeskim |
| pubmed-article:6436966 | lifeskim:mentions | umls-concept:C0038515 | lld:lifeskim |
| pubmed-article:6436966 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:6436966 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6436966 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6436966 | pubmed:dateCreated | 1984-12-19 | lld:pubmed |
| pubmed-article:6436966 | pubmed:abstractText | The serum levels of prolactin (PRL), human growth hormone (HGH), thyroid-stimulating hormone (TSH), and the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were measured in 30 females exposed to about 130 (range 65-300) ppm of styrene in the air and in 30 age-matched referents to show whether styrene exposure influences the dopaminergic tuberoinfundibular system (TIDA). The exposed subjects' serum levels of PRL were more than double the reference values and were significantly related to the urinary excretion of styrene metabolites, ie, to the sum of mandelic acid (MA) and phenylglyoxylic acid (PGA) in the "next-morning" urine spot sample. Such a relationship still proved to be statistically significant after the removal of the effects of age and duration of exposure with the method of partial correlation. The serum concentrations of HGH in the exposed workers were also higher than in the reference group. Though within the reference levels, the TSH values of the exposed subjects were significantly related to the urinary excretion of MA and PGA. These results are consistent with the dose-dependent depletion in tuberoinfundibular dopamine after experimental styrene exposure of rabbits. | lld:pubmed |
| pubmed-article:6436966 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6436966 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6436966 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6436966 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6436966 | pubmed:issn | 0355-3140 | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:ValentiGG | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:VescoviP PPP | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:FranchiniII | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:MuttiAA | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:FalzoiMM | lld:pubmed |
| pubmed-article:6436966 | pubmed:author | pubmed-author:ArfiniGG | lld:pubmed |
| pubmed-article:6436966 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6436966 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:6436966 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6436966 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6436966 | pubmed:pagination | 225-8 | lld:pubmed |
| pubmed-article:6436966 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:meshHeading | pubmed-meshheading:6436966-... | lld:pubmed |
| pubmed-article:6436966 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6436966 | pubmed:articleTitle | Neuroendocrine effects of styrene on occupationally exposed workers. | lld:pubmed |
| pubmed-article:6436966 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6436966 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6436966 | lld:pubmed |
